{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:37:01Z","timestamp":1792870621091,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274075"],"award-info":[{"award-number":["82274075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05699-7","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:34:51Z","timestamp":1783391691000},"page":"20537-20549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Herbacetin as a natural GPR35 agonist for allergic asthma relief via dual regulation of PI3K\/Akt\/mTOR and MAPK signaling"],"prefix":"10.1007","volume":"399","author":[{"given":"Ziwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2446-4411","authenticated-orcid":false,"given":"Liying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"5699_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur JS, Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13:679\u2013692. https:\/\/doi.org\/10.1038\/nri3495","journal-title":"Nat Rev Immunol"},{"key":"5699_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20071427","volume":"410","author":"JM Backer","year":"2008","unstructured":"Backer JM (2008) The regulation and function of class III PI3Ks: novel roles for Vps34. Biochem J 410:1\u201317. https:\/\/doi.org\/10.1042\/bj20071427","journal-title":"Biochem J"},{"key":"5699_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaci.2011.11.006","volume":"129","author":"PJ Barnes","year":"2012","unstructured":"Barnes PJ (2012) Severe asthma: advances in current management and future therapy. J Allergy Clin Immunol 129:48\u201359. https:\/\/doi.org\/10.1016\/j.jaci.2011.11.006","journal-title":"J Allergy Clin Immunol"},{"key":"5699_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s42003-021-02014-3","volume":"4","author":"A Boleij","year":"2021","unstructured":"Boleij A, Fathi P, Dalton W, Park B, Wu X, Huso D, Allen J, Besharati S, Anders RA, Housseau F, Mackenzie AE, Jenkins L, Milligan G, Wu S, Sears CL (2021) G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis. Commun Biol 4:585. https:\/\/doi.org\/10.1038\/s42003-021-02014-3","journal-title":"Commun Biol"},{"key":"5699_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50\u201383. https:\/\/doi.org\/10.1128\/MMBR.00031-10","journal-title":"Microbiol Mol Biol Rev"},{"key":"5699_CR6","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.2174\/0113894501268871231127105219","volume":"24","author":"A Chda","year":"2023","unstructured":"Chda A, Bencheikh R (2023) Flavonoids as G protein-coupled receptors ligands: new potential therapeutic natural drugs. Curr Drug Targets 24:1346\u20131363. https:\/\/doi.org\/10.2174\/0113894501268871231127105219","journal-title":"Curr Drug Targets"},{"key":"5699_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2147\/jaa.S468689","volume":"17","author":"X Chen","year":"2024","unstructured":"Chen X, Jiang YH, Fei X, Wang M, Liu A, Li X, Jiang Z (2024) Herbacetin inhibits asthma development by blocking the SGK1\/NF-\u03baB signaling pathway. J Asthma Allergy 17:703\u2013716. https:\/\/doi.org\/10.2147\/jaa.S468689","journal-title":"J Asthma Allergy"},{"key":"5699_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/s2213-2600(13)70128-0","volume":"1","author":"KF Chung","year":"2013","unstructured":"Chung KF (2013) New treatments for severe treatment-resistant asthma: targeting the right patient. Lancet Respir Med 1:639\u2013652. https:\/\/doi.org\/10.1016\/s2213-2600(13)70128-0","journal-title":"Lancet Respir Med"},{"key":"5699_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s2213-2600(25)00003-7","volume":"13","author":"Collaborators GAaAD","year":"2025","unstructured":"Collaborators GAaAD (2025) Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Respir Med 13:425\u2013446. https:\/\/doi.org\/10.1016\/s2213-2600(25)00003-7","journal-title":"Lancet Respir Med"},{"key":"5699_CR10","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.cell.2022.03.003","volume":"185","author":"M De Giovanni","year":"2022","unstructured":"De Giovanni M, Tam H, Valet C, Xu Y, Looney MR, Cyster JG (2022) GPR35 promotes neutrophil recruitment in response to serotonin metabolite 5-HIAA. Cell 185:1103\u20131104. https:\/\/doi.org\/10.1016\/j.cell.2022.03.003","journal-title":"Cell"},{"key":"5699_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/srep00373","volume":"2","author":"H Deng","year":"2012","unstructured":"Deng H, Hu H, Fang Y (2012) Multiple tyrosine metabolites are GPR35 agonists. Sci Rep 2:373. https:\/\/doi.org\/10.1038\/srep00373","journal-title":"Sci Rep"},{"key":"5699_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2174\/138945006777435353","volume":"7","author":"W Duan","year":"2006","unstructured":"Duan W, Wong WS (2006) Targeting mitogen-activated protein kinases for asthma. Curr Drug Targets 7:691\u2013698. https:\/\/doi.org\/10.2174\/138945006777435353","journal-title":"Curr Drug Targets"},{"key":"5699_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0031-6997(24)01478-9","volume":"53","author":"SS Ferguson","year":"2001","unstructured":"Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1\u201324","journal-title":"Pharmacol Rev"},{"key":"5699_CR14","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1096\/fj.11-196477","volume":"26","author":"N Goplen","year":"2012","unstructured":"Goplen N, Karim Z, Guo L, Zhuang Y, Huang H, Gorska MM, Gelfand E, Pag\u00e9s G, Pouyss\u00e9gur J, Alam R (2012) ERK1 is important for Th2 differentiation and development of experimental asthma. FASEB J 26:1934\u20131945. https:\/\/doi.org\/10.1096\/fj.11-196477","journal-title":"FASEB J"},{"key":"5699_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbalip.2014.12.006","volume":"1851","author":"PT Hawkins","year":"2015","unstructured":"Hawkins PT, Stephens LR (2015) PI3K signalling in inflammation. Biochim Biophys Acta 1851:882\u2013897. https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.006","journal-title":"Biochim Biophys Acta"},{"key":"5699_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.287.5455.1049","volume":"287","author":"E Hirsch","year":"2000","unstructured":"Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, Wymann MP (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287:1049\u20131053. https:\/\/doi.org\/10.1126\/science.287.5455.1049","journal-title":"Science"},{"key":"5699_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nm.2731","volume":"18","author":"ST Holgate","year":"2012","unstructured":"Holgate ST (2012) Innate and adaptive immune responses in asthma. Nat Med 18:673\u2013683. https:\/\/doi.org\/10.1038\/nm.2731","journal-title":"Nat Med"},{"key":"5699_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/FJC.0000000000000482","volume":"70","author":"PY Jean-Charles","year":"2017","unstructured":"Jean-Charles PY, Kaur S, Shenoy SK (2017) G protein-coupled receptor signaling through beta-arrestin-dependent mechanisms. J Cardiovasc Pharmacol 70:142\u2013158. https:\/\/doi.org\/10.1097\/FJC.0000000000000482","journal-title":"J Cardiovasc Pharmacol"},{"key":"5699_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/BJ20101287","volume":"432","author":"L Jenkins","year":"2010","unstructured":"Jenkins L, Brea J, Smith NJ, Hudson BD, Reilly G, Bryant NJ, Castro M, Loza MI, Milligan G (2010) Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of beta-arrestin-2 and activate Galpha13. Biochem J 432:451\u2013459. https:\/\/doi.org\/10.1042\/BJ20101287","journal-title":"Biochem J"},{"key":"5699_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107979","volume":"32","author":"B Kaya","year":"2020","unstructured":"Kaya B, Do\u00f1as C, Wuggenig P, Diaz OE, Morales RA, Melhem H, Hern\u00e1ndez PP, Kaymak T, Das S, Hruz P, Franc Y, Geier F, Ayata CK, Villablanca EJ, Niess JH (2020) Lysophosphatidic acid-mediated GPR35 signaling in CX3CR1(+) macrophages regulates intestinal homeostasis. Cell Rep 32:107979. https:\/\/doi.org\/10.1016\/j.celrep.2020.107979","journal-title":"Cell Rep"},{"key":"5699_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrd1177","volume":"2","author":"S Kumar","year":"2003","unstructured":"Kumar S, Boehm J, Lee JC (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2:717\u2013726. https:\/\/doi.org\/10.1038\/nrd1177","journal-title":"Nat Rev Drug Discov"},{"key":"5699_CR22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41590-025-02212-9","volume":"26","author":"BN Lambrecht","year":"2025","unstructured":"Lambrecht BN, Ahmed E, Hammad H (2025) The immunology of asthma. Nat Immunol 26:1233\u20131245. https:\/\/doi.org\/10.1038\/s41590-025-02212-9","journal-title":"Nat Immunol"},{"key":"5699_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1124\/pr.109.002436","volume":"62","author":"LM Luttrell","year":"2010","unstructured":"Luttrell LM, Gesty-Palmer D (2010) Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62:305\u2013330. https:\/\/doi.org\/10.1124\/pr.109.002436","journal-title":"Pharmacol Rev"},{"key":"5699_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1124\/mol.113.089482","volume":"85","author":"AE MacKenzie","year":"2014","unstructured":"MacKenzie AE, Caltabiano G, Kent TC, Jenkins L, McCallum JE, Hudson BD, Nicklin SA, Fawcett L, Markwick R, Charlton SJ, Milligan G (2014) The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35. Mol Pharmacol 85:91\u2013104. https:\/\/doi.org\/10.1124\/mol.113.089482","journal-title":"Mol Pharmacol"},{"key":"5699_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0031-6997(24)01472-8","volume":"52","author":"E Middleton Jr.","year":"2000","unstructured":"Middleton E Jr., Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673\u2013751","journal-title":"Pharmacol Rev"},{"issue":"Suppl 1","key":"5699_CR26","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1038\/sj.bjp.0706405","volume":"147","author":"G Milligan","year":"2006","unstructured":"Milligan G, Kostenis E (2006) Heterotrimeric G-proteins: a short history. Br J Pharmacol 147(Suppl 1):S46-55. https:\/\/doi.org\/10.1038\/sj.bjp.0706405","journal-title":"Br J Pharmacol"},{"key":"5699_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.physiol.69.022405.154712","volume":"69","author":"CA Moore","year":"2007","unstructured":"Moore CA, Milano SK, Benovic JL (2007) Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 69:451\u2013482. https:\/\/doi.org\/10.1146\/annurev.physiol.69.022405.154712","journal-title":"Annu Rev Physiol"},{"key":"5699_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbrc.2010.03.169","volume":"395","author":"S Oka","year":"2010","unstructured":"Oka S, Ota R, Shima M, Yamashita A, Sugiura T (2010) GPR35 is a novel lysophosphatidic acid receptor. Biochem Biophys Res Commun 395:232\u2013237. https:\/\/doi.org\/10.1016\/j.bbrc.2010.03.169","journal-title":"Biochem Biophys Res Commun"},{"key":"5699_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","volume":"215","author":"SE O'Sullivan","year":"2010","unstructured":"O\u2019Sullivan SE, Kendall DA (2010) Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 215:611\u2013616. https:\/\/doi.org\/10.1016\/j.imbio.2009.09.007","journal-title":"Immunobiology"},{"key":"5699_CR30","first-page":"173","volume":"280","author":"B Pignol","year":"1988","unstructured":"Pignol B, Etienne A, Crastes de Paulet A, Deby C, Mencia-Huerta JM, Braquet P (1988) Role of flavonoids in the oxygen-free radical modulation of the immune response. Prog Clin Biol Res 280:173\u2013182","journal-title":"Prog Clin Biol Res"},{"key":"5699_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1021\/acsptsci.0c00079","volume":"3","author":"T Quon","year":"2020","unstructured":"Quon T, Lin LC, Ganguly A, Tobin AB, Milligan G (2020) Therapeutic opportunities and challenges in targeting the orphan G protein-coupled receptor GPR35. ACS Pharmacol Transl Sci 3:801\u2013812. https:\/\/doi.org\/10.1021\/acsptsci.0c00079","journal-title":"ACS Pharmacol Transl Sci"},{"key":"5699_CR32","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.7150\/ijbs.4874","volume":"8","author":"M Rincon","year":"2012","unstructured":"Rincon M, Irvin CG (2012) Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 8:1281\u20131290. https:\/\/doi.org\/10.7150\/ijbs.4874","journal-title":"Int J Biol Sci"},{"key":"5699_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nbt.1671","volume":"28","author":"R Schroder","year":"2010","unstructured":"Schroder R, Janssen N, Schmidt J, Kebig A, Merten N, Hennen S, Muller A, Blattermann S, Mohr-Andra M, Zahn S, Wenzel J, Smith NJ, Gomeza J, Drewke C, Milligan G, Mohr K, Kostenis E (2010) Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. Nat Biotechnol 28:943\u2013949. https:\/\/doi.org\/10.1038\/nbt.1671","journal-title":"Nat Biotechnol"},{"key":"5699_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fphar.2015.00069","volume":"6","author":"DM Shore","year":"2015","unstructured":"Shore DM, Reggio PH (2015) The therapeutic potential of orphan GPCRs, GPR35 and GPR55. Front Pharmacol 6:69. https:\/\/doi.org\/10.3389\/fphar.2015.00069","journal-title":"Front Pharmacol"},{"key":"5699_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrd.2017.229","volume":"17","author":"JS Smith","year":"2018","unstructured":"Smith JS, Lefkowitz RJ, Rajagopal S (2018) Biased signalling: from simple switches to allosteric microprocessors. Nat Rev Drug Discov 17:243\u2013260. https:\/\/doi.org\/10.1038\/nrd.2017.229","journal-title":"Nat Rev Drug Discov"},{"key":"5699_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2023.117511","volume":"96","author":"Z Song","year":"2023","unstructured":"Song Z, Lu D, Sun J, Ye Y, Fang J, Wang K, Guo S, Zhang Q, He X, Xie X, Shen J (2023) Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD. Bioorg Med Chem 96:117511. https:\/\/doi.org\/10.1016\/j.bmc.2023.117511","journal-title":"Bioorg Med Chem"},{"key":"5699_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/1087057113475480","volume":"18","author":"C Southern","year":"2013","unstructured":"Southern C, Cook JM, Neetoo-Isseljee Z, Taylor DL, Kettleborough CA, Merritt A, Bassoni DL, Raab WJ, Quinn E, Wehrman TS, Davenport AP, Brown AJ, Green A, Wigglesworth MJ, Rees S (2013) Screening beta-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. J Biomol Screen 18:599\u2013609. https:\/\/doi.org\/10.1177\/1087057113475480","journal-title":"J Biomol Screen"},{"key":"5699_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2015.05.017","volume":"23","author":"AK Stark","year":"2015","unstructured":"Stark AK, Sriskantharajah S, Hessel EM, Okkenhaug K (2015) PI3K inhibitors in inflammation, autoimmunity and cancer. Curr Opin Pharmacol 23:82\u201391. https:\/\/doi.org\/10.1016\/j.coph.2015.05.017","journal-title":"Curr Opin Pharmacol"},{"key":"5699_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5483\/bmbrep.2008.41.6.415","volume":"41","author":"PG Suh","year":"2008","unstructured":"Suh PG, Park JI, Manzoli L, Cocco L, Peak JC, Katan M, Fukami K, Kataoka T, Yun S, Ryu SH (2008) Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 41:415\u2013434. https:\/\/doi.org\/10.5483\/bmbrep.2008.41.6.415","journal-title":"BMB Rep"},{"key":"5699_CR40","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1016\/j.febslet.2006.08.015","volume":"580","author":"Y Taniguchi","year":"2006","unstructured":"Taniguchi Y, Tonai-Kachi H, Shinjo K (2006) Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett 580:5003\u20135008. https:\/\/doi.org\/10.1016\/j.febslet.2006.08.015","journal-title":"FEBS Lett"},{"key":"5699_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jphs.2025.08.009","volume":"159","author":"K Tokuyama","year":"2025","unstructured":"Tokuyama K, Yasuda H, Saito M, Hayashi S, Kato S (2025) Protective role of orphan G protein-coupled receptor GPR35 in the pathogenesis of colitis through regulating epithelial barrier function and immune responses. J Pharmacol Sci 159:191\u2013201. https:\/\/doi.org\/10.1016\/j.jphs.2025.08.009","journal-title":"J Pharmacol Sci"},{"key":"5699_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2019.103334","volume":"273","author":"A Tripathi","year":"2020","unstructured":"Tripathi A, Kumar M, Kaur P, Kumar B, Sagi SSK (2020) Efficacy of Quercetin as a potent sensitizer of \u03b22-AR in combating the impairment of fluid clearance in lungs of rats under hypoxia. Respir Physiol Neurobiol 273:103334. https:\/\/doi.org\/10.1016\/j.resp.2019.103334","journal-title":"Respir Physiol Neurobiol"},{"key":"5699_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm3290","volume":"13","author":"B Vanhaesebroeck","year":"2012","unstructured":"Vanhaesebroeck B, Stephens L, Hawkins P (2012) PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol 13:195\u2013203. https:\/\/doi.org\/10.1038\/nrm3290","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5699_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114356","volume":"279","author":"X Wei","year":"2021","unstructured":"Wei X, Zhao Z, Zhong R, Tan X (2021) A comprehensive review of herbacetin: from chemistry to pharmacological activities. J Ethnopharmacol 279:114356. https:\/\/doi.org\/10.1016\/j.jep.2021.114356","journal-title":"J Ethnopharmacol"},{"key":"5699_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.118.016899","volume":"72","author":"SG Wendell","year":"2020","unstructured":"Wendell SG, Fan H, Zhang C (2020) G protein-coupled receptors in asthma therapy: pharmacology and drug action. Pharmacol Rev 72:1\u201349. https:\/\/doi.org\/10.1124\/pr.118.016899","journal-title":"Pharmacol Rev"},{"key":"5699_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ceb.2013.10.008","volume":"27","author":"JW Wisler","year":"2014","unstructured":"Wisler JW, Xiao K, Thomsen AR, Lefkowitz RJ (2014) Recent developments in biased agonism. Curr Opin Cell Biol 27:18\u201324. https:\/\/doi.org\/10.1016\/j.ceb.2013.10.008","journal-title":"Curr Opin Cell Biol"},{"key":"5699_CR47","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrd4052","volume":"12","author":"D Wootten","year":"2013","unstructured":"Wootten D, Christopoulos A, Sexton PM (2013) Emerging paradigms in GPCR allostery: implications for drug discovery. Nat Rev Drug Discov 12:630\u2013644. https:\/\/doi.org\/10.1038\/nrd4052","journal-title":"Nat Rev Drug Discov"},{"key":"5699_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114488","volume":"280","author":"F Xu","year":"2021","unstructured":"Xu F, Hou T, Shen A, Jin H, Xiao Y, Yu W, Li X, Wang J, Liu Y, Liang X (2021) Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of Coronavirus Disease 2019 (COVID-19) by label-free integrative pharmacology assays. J Ethnopharmacol 280:114488. https:\/\/doi.org\/10.1016\/j.jep.2021.114488","journal-title":"J Ethnopharmacol"},{"key":"5699_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117370","volume":"242","author":"Y Yang","year":"2025","unstructured":"Yang Y, Guan W (2025) From orphan receptor to inflammation regulation: the role of GPR35 in the pathogenesis of depression. Biochem Pharmacol 242:117370. https:\/\/doi.org\/10.1016\/j.bcp.2025.117370","journal-title":"Biochem Pharmacol"},{"key":"5699_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114416","volume":"153","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Meng B, Tang M, Li C, Xu Y, Pan J, Yu L, Li Y, Yang Y, Liu Y, Li H, Hu L, Wu T, Li J (2025) Activation of GPR35 by kynurenic acid inhibits IL-1\u03b2 secretion in macrophages during CR-hvKP-induced pneumonia. Int Immunopharmacol 153:114416. https:\/\/doi.org\/10.1016\/j.intimp.2025.114416","journal-title":"Int Immunopharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05699-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05699-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05699-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:02:31Z","timestamp":1792868551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05699-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":50,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5699"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05699-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}